An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints (Q3299101): Difference between revisions
From MaRDI portal
Created a new Item |
Created claim: Wikidata QID (P12): Q92553470, #quickstatements; #temporary_batch_1719332822301 |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1002/bimj.201900022 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2968902065 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q92553470 / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 17:31, 25 June 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints |
scientific article |
Statements
An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints (English)
0 references
17 July 2020
0 references
Bayesian adaptive design
0 references
coprimary endpoints
0 references
nested endpoints
0 references
ordinal endpoint
0 references
phase II trials
0 references
predictive probability
0 references
